Researchers are pushing to restrict access to pesticides, a leading means of suicide in agricultural areas of developing nations. ( New York Times )

Add-on D-serine failed to improve depressive symptoms versus placebo in a small randomized trial of inpatients with major depressive disorder (MDD) , but showed some promise in the subset with severe MDD. ( Journal of Affective Disorders )

Patients with schizophrenia treated with an investigational long-acting oral weekly formulation of risperidone (LYN 005) remained clinically stable with no unexpected safety signals, a phase III trial found. ( Lancet Psychiatry )

There were more psychiatric adverse events reported to the FDA Adverse Event Reporting System by women taking systemic versus localized hormone replacement therapy.

See Full Page